Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate Dosing in Overweight/Obese Preeclampsia
NCT06486025Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of magnesium sulfate in preeclampsia (2 arms), sponsored by Ain Shams University. Primary endpoint: Serum magnesium sulfate concentration at 24 hours. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06486025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06486025.